Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Citi
Cerilliant
Julphar
Healthtrust
Baxter
Fuji
Moodys

Generated: June 21, 2018

DrugPatentWatch Database Preview

PROCHLORPERAZINE EDISYLATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Prochlorperazine Edisylate, and when can generic versions of Prochlorperazine Edisylate launch?

Prochlorperazine Edisylate is a drug marketed by Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, and Alpharma Us Pharms. and is included in fifteen NDAs.

The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
Drug patent expirations by year for PROCHLORPERAZINE EDISYLATE
Pharmacology for PROCHLORPERAZINE EDISYLATE
Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Synonyms for PROCHLORPERAZINE EDISYLATE
1,2-Ethanedisulfonic acid, compd. with 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (1:1)
10H-Phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, 1,2-ethanedisulfonate (1:1)
1257-78-9
2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine edisylate
2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine 1,2-ethanedisulfonate (1:1)
2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine 1,2-ethanedisulfonate (1:1)
2-CHLORO-10-[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE; ETHANE-1,2-DISULFONIC ACID
2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine; ethane-1,2-disulfonic acid
7081-50-7
AC1L3M77
AC1Q6XA2
AKOS030228220
API0025987
C20H25N3S.C2H6O6S2
C22H30ClN3O6S3
CCG-39235
CHEMBL1201154
Compazine Injection
Compazine syrup
Compazine syrup (TN)
D02609
DTXSID4074483
EINECS 215-019-1
Ethane-1,2-disulphonic acid, compound with 2-chloro-10-(3-(4-methylpiperazin-1-yl)propyl)-10H-phenothiazine (1:1)
HMS1920L08
HMS2092C09
HMS2234E05
HMS3372M12
HMS501E15
KS-000000G8
LS-105400
MLS001148133
MolPort-003-666-268
NCGC00094768-01
NCGC00094768-02
NCGC00094768-03
NSC-665801
NSC-757299
NSC665801
NSC757299
PG20W5VQZS
Pharmakon1600-01500505
Phenothiazine, 2-chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-, ethanedisulfonate
PL010690
Prochlorperazine edisylate (USP)
Prochlorperazine edisylate [USAN]
Prochlorperazine edisylate [USP]
Prochlorperazine Edisylate, USP
Prochlorperazine ethane disulfonate
prochlorperazine ethanedisulfonate
SCHEMBL40855
SMR000653454
SPECTRUM1500505
UNII-PG20W5VQZS
W0065

US Patents and Regulatory Information for PROCHLORPERAZINE EDISYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate CONCENTRATE;ORAL 088598-001 Oct 25, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 040505-001 May 30, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089703-001 Apr 7, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089903-001 Aug 29, 1989 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
AstraZeneca
Baxter
Federal Trade Commission
Daiichi Sankyo
Farmers Insurance
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.